<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>8
<FILENAME>l99097aexv10w4.txt
<DESCRIPTION>EXHIBIT 10.4
<TEXT>
<PAGE>
                                                                    EXHIBIT 10.4

                                 AMENDMENT NO. 1

                                     TO THE

                      COLLABORATIVE CLINICAL RESEARCH, INC.
          AMENDED AND RESTATED 1996 OUTSIDE DIRECTORS STOCK OPTION PLAN

         This Amendment No. 2 (the "Amendment") to the Collaborative Clinical
Research, Inc. Amended and Restated 1996 Outside Directors Stock Option Plan is
made this 20th day of May, 1997 by Collaborative Clinical Research, Inc. (the
"Company").

                               W I T N E S S E T H

         WHEREAS, on September 20, 1996, the Company's shareholders approved and
adopted the Collaborative Clinical Research, Inc. Amended and Restated 1996
Outside Directors Stock Option Plan (the "Plan"); and

         WHEREAS, at a meeting held on September 17, 1998, the Company's Board
of Directors deemed it necessary to amend certain provisions of the Plan in
order to (i) increase the number of Common Shares subject to the Plan, (ii)
modify the formula for automatic option grants, (iii) modify the vesting period
of options granted and (iv) require the execution of written agreements for each
option grant.

         NOW, THEREFORE, in consideration of the foregoing, the Plan is amended
as follows:

         1. COMMON SHARES SUBJECT TO THE PLAN. The second paragraph of Section 3
of the Plan is deleted in its entirety and the following paragraph is
substituted in lieu thereof:

         "Subject to the provisions of the next succeeding paragraph of this
Section 3, the aggregate number of Common Shares for which options may be
granted under the Plan shall be Fifty Thousand (50,000) Common Shares."

         IN WITNESS WHEREOF, Collaborative Clinical Research, Inc., by its
appropriate officers duly authorized, has executed this Amendment No. 1 as of
the 20th day of May, 1997.

                                          COLLABORATIVE CLINICAL RESEARCH, INC.

                                          By:
                                            /s/ JEFFREY A. GREEN
                                            ------------------------------------
                                            Jeffrey A. Green, Pharm.D., FCP,
                                            President and Chief Executive
                                              Officer

                                          By:
                                            /s/ TERRY C. BLACK
                                            ------------------------------------
                                            Terry C. Black
                                            Vice President of Finance and Chief
                                             Financial Officer



</TEXT>
</DOCUMENT>
